start portlet menu bar

Visualitzador de contingut web

Display portlet menu
end portlet menu bar

Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

Inici Coneixement Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

The aim of this study was to compare the humoral immune response provided by four commercialised reproductive vaccines against swine erysipelas (SE) and porcine parvovirus (PPV), under field conditions in Denmark. 

Sobre aquest article

Publicat en

European Symposium of Porcine Health Management, 2018

Data

10 jul. 2018

Autors

Pedersen, K.S.; Camprodon, A.; Llopart, D.; Jorda, R.; Strunz, A.M.

Resum

Gilts vaccinated with ERYSENG® PARVO exhibited the highest serological response compared with animals vaccinated with one of the other three commercialised vaccines against E. rhusiopathiae.

Productes relacionats

Compartir